When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Tic disorders

Última revisión: 1 Feb 2026
Última actualización: 17 Nov 2022

Resumen

Definición

Anamnesis y examen

Principales factores de diagnóstico

  • observed tics
  • premonitory sensation
  • ability to suppress tics
  • symptoms may improve when distracted
  • otherwise normal neurologic exam
Todos los datos

Otros factores de diagnóstico

  • symptoms worse with stress, anxiety, excitement, or transitions
  • variable severity over time
  • symptoms of comorbid psychiatric disorder
Todos los datos

Factores de riesgo

  • onset at age <18 years
  • male sex
  • family history of tics
  • family history of obsessive-compulsive disorder (OCD), ADHD, or depression
  • prenatal maternal smoking
  • history of OCD or ADHD
  • history of autism spectrum disorder (ASD)
Todos los datos

Pruebas diagnósticas

Primeras pruebas diagnósticas para solicitar

  • clinical diagnosis
Todos los datos

Pruebas diagnósticas que deben considerarse

  • MRI brain with and without contrast
  • electroencephalogram
  • cerebrospinal fluid analysis (lumbar puncture)
Todos los datos

Algoritmo de tratamiento

Agudo

symptoms not interfering with activities of daily living

symptoms interfering with activities of daily living: nonpregnant

severe tics refractory to behavioral and pharmacologic therapies

symptoms interfering with activities of daily living: pregnant

Colaboradores

Autores

Tamara Pringsheim, MD, FRCPC

Professor

University of Calgary

Department of Clinical Neurosciences, Psychiatry, Pediatrics, and Community Health Sciences

Calgary

Canada

Divulgaciones

TP has received research grants for Tourette syndrome from Alberta Health and the Alberta Children's Hospital Research Institute. TP is an author of several references cited in this topic.

Agradecimientos

Professor Tamara Pringsheim would like to gratefully acknowledge Dr Tanya K. Murphy, Dr Fatima Masumova, Dr Cathy L. Budman, Dr Amber Stocco, Dr Migvis Monduy, and Dr Bobbi Hopkins, previous contributors to this topic.

Divulgaciones

FM, AS, MM, and BH declare that they have no competing interests. TKM has received research grants from Auspex Pharmaceuticals, the National Institute of Mental Health, Shire Pharmaceuticals, Pfizer Inc., F. Hoffman-La Roche Ltd., AstraZeneca Pharmaceuticals, Centers for Disease Control and Prevention, Massachusetts General Hospital, Sunovion Pharmaceuticals, Neurocrine Bioscience, Psyadon Pharmaceuticals, and PANDAS Network; she is on the advisory board for the International Obsessive Compulsive Foundation; she is also an author of several references cited in this topic. CLB has received research funding from Otsuka, Psyadon, Auspex, Teva, Neurocrine, and Synchroneuron Pharmaceuticals; she is a consultant for Bracket and a paid speaker for the Centers for Disease Control and Prevention (CDC) - National Tourette Syndrome Association Partnership; she is an author of several references cited in this topic.

Revisores por pares

Francis Filloux, MD

Chief

Division of Pediatric Neurology

University of Utah School of Medicine

Salt Lake City

UT

Divulgaciones

FF declares that he has no competing interests.

Agradecimiento de los revisores por pares

Los temas de BMJ Best Practice se actualizan de forma continua de acuerdo con los desarrollos en la evidencia y en las guías. Los revisores por pares listados aquí han revisado el contenido al menos una vez durante la historia del tema.

Divulgaciones

Las afiliaciones y divulgaciones de los revisores por pares se refieren al momento de la revisión.

Referencias

Nuestros equipos internos de evidencia y editoriales colaboran con colaboradores expertos internacionales y revisores pares para garantizar que brindemos acceso a la información más clínicamente relevante posible.

Artículos principales

Murphy TK, Lewin AB, Storch EA, et al. Practice parameter for the assessment and treatment of children and adolescents with tic disorders. J Am Acad Child Adolesc Psychiatry. 2013 Dec;52(12):1341-59.Texto completo  Resumen

Plessen KJ, Bansal R, Peterson BS. Imaging evidence for anatomical disturbances and neuroplastic compensation in persons with Tourette syndrome. J Psychosom Res. 2009 Dec;67(6):559-73.Texto completo  Resumen

Pringsheim T, Okun MS, Müller-Vahl K, et al. Practice guideline recommendations summary: treatment of tics in people with Tourette syndrome and chronic tic disorders. Neurology. 2019 May 7;92(19):896-906.Texto completo  Resumen

Pringsheim T, Holler-Managan Y, Okun MS, et al. Comprehensive systematic review summary: treatment of tics in people with Tourette syndrome and chronic tic disorders. Neurology. 2019 May 7;92(19):907-15.Texto completo  Resumen

Kuo SH, Jimenez-Shahed J. Topiramate in treatment of Tourette syndrome. Clin Neuropharmacol. 2010 Jan-Feb;33(1):32-4. Resumen

Bloch MH, Panza KE, Landeros-Weisenberger A, et al. Meta-analysis: treatment of attention-deficit/hyperactivity disorder in children with comorbid tic disorders. J Am Acad Child Adolesc Psychiatry. 2009 Sep;48(9):884-93.Texto completo  Resumen

Artículos de referencia

Una lista completa de las fuentes a las que se hace referencia en este tema está disponible para los usuarios con acceso a todo BMJ Best Practice.
  • Diferenciales

    • Functional tic-like behaviors
    • Obsessive-compulsive disorder (OCD)
    • Stereotypies
    Más Diferenciales
  • Guías de práctica clínica

    • Diagnosing tic disorders
    • Treatment of tics in people with Tourette syndrome and chronic tic disorders
    Más Guías de práctica clínica
  • Folletos para el paciente

    ADHD: what is it?

    Obsessive-compulsive disorder

    Más Folletos para el paciente
  • padlock-lockedInicie sesión o suscríbase para acceder a todo el BMJ Best Practice

El uso de este contenido está sujeto a nuestra cláusula de exención de responsabilidad